It is a home & lifestyle private limited company based in New Delhi, Delhi, India, established in 2015.
2015 | New Delhi, Delhi, India | ActiveSilver Line Laboratories Private Limited, a active private limited company, was established on 11 March 2015 in New Delhi, Delhi, India. Engaging in lifestyle products & accessories manufacturing within the hospital and medical care sector, it holds CIN: U74140DL2015PTC277776. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.75 M.
It upholds a compliant status. Employing 27 professional, Its leadership includes Roopa Sahni (Director), Baldev Sahni (Director), Gagan Deep Sahani (Director). Past directors included Ashok Kumar Sahni. It holds ₹3.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 90/52 Malviya Nagar, New Delhi, Delhi, 110017.
U74140DL2015PTC277776
277776
11 March 2015
₹5.00 M
₹0.75 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Silver Line Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Roopa Sahni | Director | 02 Feb 2021 | Current |
| Baldev Sahni | Director | 06 Mar 2017 | Current |
| Gagan Deep Sahani | Director | 11 Mar 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Feb 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Silver Line Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 92.88% increase. The company also saw a substantial improvement in profitability, with a 85.74% increase in profit. The company's net worth Soared by an impressive increase of 43.33%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Silver Line Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹30,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jul 2025 | Others | ₹2.00 Cr | Open |
| 30 May 2024 | Others | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
Silver Line Laboratories has a workforce of 27 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Silver Line Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Silver Line Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 20.00 M with Charge ID 101144391 was registered on 28 Jul 2025. was recorded as a recent event.
Progress on Silver Line Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity A charge with Others amounted to Rs. 10.00 M with Charge ID 100930540 was registered on 30 May 2024. was completed.
The activity Silver Line Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on Roopa Sahni was appointed as a Director was appointed as a Director on 02 Feb 2021 & has been associated with this company since 4 years 10 months . was documented.
Progress on Baldev Sahni was appointed as a Director was appointed as a Director on 06 Mar 2017 & has been associated with this company since 8 years 8 months . was documented.
The CIN of Silver Line Laboratories Private Limited is U74140DL2015PTC277776.
Silver Line Laboratories Private Limited is headquartered at 90/52 Malviya Nagar, New Delhi, Delhi, 110017.
Silver Line Laboratories Private Limited was incorporated on 11 March 2015.
The current directors of Silver Line Laboratories Private Limited are
The primary industry of Silver Line Laboratories Private Limited is Hospital And Medical Care.
Silver Line Laboratories Private Limited is unlisted.
The authorized capital of Silver Line Laboratories Private Limited is ₹5.00 M, and the paid-up capital is ₹0.75 M.
The compliance status of Silver Line Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX